---
title: "Shandong Xinhua Pharmaceutical says valsartan capsules obtained drug registration certificate from NMPA"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/270982932.md"
description: "Shandong Xinhua Pharmaceutical says valsartan capsules obtained drug registration certificate from NMPA"
datetime: "2025-12-29T10:35:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/270982932.md)
  - [en](https://longbridge.com/en/news/270982932.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/270982932.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/270982932.md) | [繁體中文](https://longbridge.com/zh-HK/news/270982932.md)


# Shandong Xinhua Pharmaceutical says valsartan capsules obtained drug registration certificate from NMPA



### Related Stocks

- [Xinhua Pharm (000756.CN)](https://longbridge.com/en/quote/000756.CN.md)
- [SHANDONG XINHUA (00719.HK)](https://longbridge.com/en/quote/00719.HK.md)

## Related News & Research

- [Shandong Xinhua pharmaceutical received drug registration certificate for alendronate sodium oral solution](https://longbridge.com/en/news/263711537.md)
- [Shandong Xinhua Pharmaceutical Obtains Drug Registration Certificate for Bisoprolol Fumarate Tablets in China](https://longbridge.com/en/news/260857016.md)
- [JD.com Q4 earnings on deck: What to expect](https://longbridge.com/en/news/277814545.md)
- [RUBBER-Japan futures drift lower on falling oil, weaker spot prices](https://longbridge.com/en/news/278047370.md)
- [RUBBER-Japan futures extend losses amid uncertainty from Middle East war](https://longbridge.com/en/news/277711071.md)